Pieter Meer - Profile and Investment Details

Investor Profile

Pieter Meer is a Venture Capital, Private Equity Firm based in Utrecht, Utrecht, The Netherlands with a diverse investment portfolio that includes companies such as Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation, Breath Therapeutics, Roche Glycart, Innate Pharma, Inova Labs, Moximed, Nightbalance, Eargo, Inari Medical, STAT-Dx, VerzuimVitaal, Ascendis Pharma, SANIFITBG Medicine, Prosonix, Nyxoah, Draupnir Bio, Axonics Modulation Technologies, Levicept, Big Health, Calypso Biotech, NIZO, Chroma Therapeutics, Pieris AG, LUMICKS, Ablative Solutions, Symphogen, MTM Laboratories, Definiens, Fysius Rugexperts, Agendia, Vesper Medical, Galapagos, Lumeon, Pharmaline, Volta Medical, Amphista Therapeutics, Withings, Novicare, ProFibrix, Ablynx, Conatus Pharmaceuticals, Zetacom, BionX™ Medical Technologies, Acacia Pharma, CVRx, Lava Therapeutics, Stepping Stones Home & Care, Evotec, Vapotherm, FlowCardia, FIRE1, . Over time, Pieter Meer has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Pieter Meer is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Hospitals, Drug Discovery, Wellness, Investment Management, Apps, Healthcare Innovation, Telemedicine, Life Science, Emerging Markets, Portfolio Management, Medical Technologies, Artificial Intelligence (AI), Analytics, Due Diligence Services, Finance, Software, Biotechnology, Healthcare IT, Medical Devices, Sourcing, Podcasts, Market Research, Elderly Care, Legal Tech, Capital Raising, Consulting, Hardware, Personalized Medicine, Health Diagnostics, Digital Health, Regulatory Compliance, Medical Supplies, Medical, Information Technology, B2B, Therapeutics, Health Tech, Risk Management, Business Intelligence may find it worthwhile to explore potential connections with Pieter Meer, as their portfolio suggests a familiarity and interest in this area.

Understanding Pieter Meer’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.